To exclude that the effect of SecinH3 was restricted to A549 cells the experiments were repeated in H460 cells, a NSCLC cell line expressing also wild-type EGFR but a different KRas mutant, namely G61H (Fig. 1C). The gene discussed is KRAS; the disease is non-small cell lung carcinoma.